Clinical trials
Phase 2/3 Inflammatory Bowel Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 5 |
| Unknown status | 4 |
| Recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mostafa Bahaa | 2 |
| Theravance Biopharma | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Acibadem University | 1 |
| AstraZeneca | 1 |
| Changhai Hospital | 1 |
| Charite University, Berlin, Germany | 1 |
| Mohammed Bin Rashid University of Medicine and Health Sciences | 1 |
| Nationwide Children's Hospital | 1 |
| Oslo University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 19 |
| Colitis, Ulcerative | 7 |
| Crohn Disease | 7 |
| Colitis | 2 |
| Anastomotic Leak | 1 |
| Colonic Neoplasms | 1 |
| Digestive System Diseases | 1 |
| Diverticular Diseases | 1 |
| Fatigue | 1 |
| Gastrointestinal Diseases | 1 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.